---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-011455"
form_type: "8-K"
ticker: "TCMD"
cik: "0001027838"
company_name: "TACTILE SYSTEMS TECHNOLOGY INC"
filed_at: "2022-08-01T23:59:59+00:00"
generated_at: "2026-06-24T06:16:38.302429+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Tactile Medical Q2 revenue $59.6M (+17% YoY); raises FY22 revenue guidance to $238-242M

## Summary
- Net loss $4.6M ($0.23/share) vs net income $1.3M ($0.07) in Q2 2021; adjusted EBITDA $1.7M vs $4.1M.
- Airway clearance products added $8.0M revenue; lymphedema sales up 1% YoY.
- Full-year 2022 revenue guidance raised to $238-242M from prior $235-240M (14-16% growth).
- Operating loss widened to $4.1M from $0.1M; cash $23.4M, debt $50.5M.

## SEC filing metadata
- accession: 0001558370-22-011455
- form_type: 8-K
- ticker: TCMD
- cik: 0001027838
- company_name: TACTILE SYSTEMS TECHNOLOGY INC
- filed_at: 2022-08-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1027838/000155837022011455/0001558370-22-011455-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1027838/000155837022011455/tcmd-20220801x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-011455
- JSON: https://secwatch.observer/filing/0001558370-22-011455.json
- Plain text: https://secwatch.observer/filing/0001558370-22-011455.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.